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Open access under CC BLow-afﬁnity extracellular protein interactions are critical for cellular recognition processes, but existing
methods to detect them are limited in scale, making genome-wide interaction screens technically chal-
lenging. To address this, we report here the miniaturization of the AVEXIS (avidity-based extracellular
interaction screen) assay by using protein microarray technology. To achieve this, we have developed
protein tags and sample preparation methods that enable the parallel puriﬁcation of hundreds of recom-
binant proteins expressed in mammalian cells. We benchmarked the protein microarray-based assay
against a set of known quantiﬁed receptor–ligand pairs and show that it is sensitive enough to detect
even very weak interactions that are typical of this class of interactions. The increase in scale enables
interaction screening against a dilution series of immobilized proteins on the microarray enabling the
observation of saturation binding behaviors to show interaction speciﬁcity and also the estimation of
interaction afﬁnities directly from the primary screen. These methodological improvements now permit
screening for novel extracellular receptor–ligand interactions on a genome-wide scale.
 2012 Elsevier Inc. Open access under CC BY license.Extracellular protein–protein interactions between secreted or
membrane-tethered proteins are critical for intercellular recogni-
tion processes that initiate signaling cascades and provide cellular
cohesion within multicellular organisms [1]. These proteins are en-
coded by approximately 25 to 30% of human genes [2], but despite
their abundance and importance, interactions involving these pro-
teins are frequently underrepresented in large-scale systematic
protein interaction datasets [3,4]. One plausible reason for this is
the unusual biochemical properties of membrane receptor pro-
teins; they are amphipathic, making them difﬁcult to solubilize
in their native conformation, and they contain functionally impor-
tant posttranslational modiﬁcations such as disulﬁde bonds and
hydrophilic glycans that are not added in many heterologous and
cell-free expression systems. In addition, the interaction afﬁnities
between cell surface proteins are typically very low, having half-
lives that are less than 1 s [1,5], making them difﬁcult to detect
using protocols that involve wash steps. The transient nature of
these interactions and the necessity for posttranslational modiﬁca-
tions make currently popular high-throughput assays generally
unsuitable to detect this class of protein interactions.
Despite the biochemical difﬁculties of identifying novel low-
afﬁnity extracellular receptor–ligand interactions, several scalable
methods that take account of some or all of these biochemical chal-
lenges have been devised [6–14]. The approach developed by ourY license.laboratory, called AVEXIS (avidity-based extracellular interaction
screen),1 [15] involves expressing the entire extracellular region of
membrane-tethered receptors or secreted proteins as soluble recom-
binant proteins by mammalian cells. The ectodomain fragments are
produced as both monobiotinylated baits that can be captured on
streptavidin-coated solid phases and b-lactamase-tagged pentamer-
ized preys. The cartilage oligomeric matrix protein (COMP) peptide-
mediated pentamerization increases the overall binding avidity to
enable reliable detection of interactions having monomeric half-lives
of60.1 s (KD  50 lM) [15], which is within the lower threshold sug-
gested to be of physiological relevance [1,16], whereas b-lactamase
enables the enzymatic detection of captured preys. This assay now
permits the systematic screening of thousands of binary interactions
and has been used to explore cellular recognition events during early
vertebrate development [15–19] and host pathogen interactions [20].
However, the current implementation has several disadvantages.
First, the preparation of protein libraries using large volumes
(>50 ml) of mammalian tissue culture supernatants is labor-intensive
and makes storing and sharing these resources difﬁcult. Second, the
microtiter plate-based assay uses a comparatively large amount of
protein, limiting the size of our interaction screens to just hundreds
of proteins. In addition, baits expressed at levels below the assay1 Abbreviations used: AVEXIS, avidity-based extracellular interaction screen; NTA,
nitrilotriacetic acid; ELISA, enzyme-linked immunosorbent assay; PBS, phosphate-
buffered saline; BSA, bovine serum albumin; HRP, horseradish peroxidase; SPR,
surface plasmon resonance.
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gated free biotin must be removed by dialysis from the bait prepara-
tions before capture on streptavidin-coated microtiter plates. This
latter step, in particular, is cumbersome due to the signiﬁcant number
(>100 proteins) and large volumes (50 ml) of tissue culture superna-
tant used.
Protein microarray technology has become a useful tool in the
discovery of novel protein–protein interactions, providing a meth-
od of capturing thousands of proteins in ordered arrays [21–26].
The use of microarrays has several advantages. Screening is per-
formed in vitro, which importantly provides experimental control
over parameters critically affecting assay detection thresholds such
as protein concentrations, temperature, washing stringencies, and
cofactor dependence. In addition, the miniaturized format requires
only tiny amounts of biological sample, and the arrays can be con-
veniently stored and transported. Protein microarrays have been
previously used to detect extracellular protein interactions in-
volved in host–pathogen interactions [27] and low-afﬁnity leuko-
cyte interactions [28]. The proteins that are spotted are usually
expressed in bacterial systems (most commonly Escherichia coli)
or synthesized in situ from arrayed plasmid expression using
cell-free expression systems [29–32]. Although convenient, these
systems do not add the structurally critical posttranslational mod-
iﬁcations such as disulﬁde bonds or glycans that are necessary to
retain the extracellular binding properties of membrane-tethered
or secreted proteins.
Here, we show how we have improved our recombinant protein
sample preparation workﬂows and miniaturized the AVEXIS assay
so that it can be used on a protein microarray format. Importantly,
we benchmarked our protein microarray-based interaction assay
against a set of well-characterized low-afﬁnity extracellular pro-
tein interactions of known binding strengths and showed that
the microarray-based method is at least as sensitive as the plate-
based AVEXIS assay but uses approximately ﬁve orders of magni-
tude less protein. This new implementation of the AVEXIS assay
will now permit us to increase the size of our interaction screens
to a genome-wide scale.Materials and methods
Cell culture and protein expression
All proteins were produced by transient transfection using an
HEK293E expression system as described in Refs. [15,33] except
that cells were cultured in Freestyle medium (Invitrogen) supple-
mented with 1% fetal bovine serum. The original bait proteins con-
tained a C-terminal peptide sequence, which in the presence of the
E. coli enzyme, BirA, and D-biotin is enzymatically monobiotinylat-
ed at a speciﬁc lysine residue (see ‘‘Bio’’ tag in Fig. 1A). An N-termi-
nal signal peptide was added to the BirA protein to direct it to the
secretory pathway, enabling efﬁcient biotinylation of the secreted
bait proteins by simply cotransfecting plasmids encoding both the
modiﬁed BirA enzyme and the bait construct [15,18,19]. Cells were
transfected and then incubated for 6 days before supernatants
were harvested by removing cells by centrifugation at 3220g for
5 min and cell debris by ﬁltering (0.2-lm ﬁlter). All samples were
stored at 4 C until use.Protein puriﬁcation
Proteins were puriﬁed from spent tissue culture media using
Ni2+–NTA (nitrilotriacetic acid) resin (GE Healthcare) essentially
as described previously [15]. For plate-based puriﬁcations, 96-well
His MultiTrap HP plates (GE Healthcare) were used in the custom-
built, piston-driven sample loading apparatus as described inAdditional Data File 1 of the supplementary material. Brieﬂy, plates
were spun down to remove any storage solutions and washed once
with wash buffer (20 mM phosphate, 0.5 M NaCl, and 40 mM imid-
azole, pH 7.4) before samples were loaded. After loading was com-
pleted, plates were removed and washed twice with wash buffer
before being eluted with 100 to 300 ll of elution buffer (20 mM
phosphate, 0.5 M NaCl, and 400 mM imidazole, pH 7.4).
Bait and prey protein normalization
Bait and prey proteins were normalized as described previously
[15]. Brieﬂy, concentrations of puriﬁed biotinylated bait proteins
were determined by enzyme-linked immunosorbent assay (ELISA)
on streptavidin-coated plates (Nunc) and then normalized by dilu-
tion. The prey proteins were normalized using the b-lactamase
enzymatic activity. Prey proteins were normalized by concentrat-
ing with 30,000-MWCO (molecular weight cutoff) spin concentra-
tors or diluting in the same manner as the bait proteins. To
determine the fraction of protein that was biotinylated, proteins
were normalized using an inhibition ELISA with the anti-rat Cd4
monoclonal antibody, OX68 (AbD Serotec).
Protein microarray production
Normalized bait proteins were diluted in phosphate-buffered
saline (PBS) supplemented with 0.02% Tween and 0.5% bovine ser-
um albumin (BSA) prior to printing. Bait proteins were printed on
streptavidin-coated slides that also contained an inert hydrogel
coating (XanTec) using a MicroGrid II (Digilab) arrayer mounted
with 200-lm solid contact pins at 22 C and 70% relative humidity
according to the manufacturer’s instructions. After printing, slides
were incubated for 1 h at 70% relative humidity at 22 C, washed in
PBS for 1 h at 22 C, spin-dried, and stored at 20 C until use.
Microarray AVEXIS screening
Prior to interaction screening, printed slides were rinsed three
times with MilliQ H2O and blocked with PBS containing 1% BSA
and 10 mM D-biotin for 45 min. Slides were then incubated with
normalized prey proteins for 1 h at 22 C, washed three times in
PBS/0.5% Tween, incubated with 1:1000 anti-Flag horseradish
peroxidase (HRP) antibody (Sigma) for 1 h at 22 C, and ﬁnally
detected by TSA Alexa 555 substrate (Invitrogen) for 1 h at 22 C.
Slides were washed three times in PBS containing 0.1% Tween 20
with gentle rocking at 22 C between each incubation step. Positive
interactions were identiﬁed by scanning slideswith a ScanArray Ex-
press Microarray Scanner (PerkinElmer) at a 550-nm wavelength.Results
A dual protein tag for recombinant protein puriﬁcation
and capture on streptavidin-coated substrates
Our original AVEXIS assay required producing ectodomain frag-
ments of receptor proteins expressed in mammalian cells as solu-
ble, tagged recombinant biotinylated bait proteins. The need to
increase the concentration of bait proteins expressed below the as-
say threshold and remove excess free biotin from protein prepara-
tions, however, prevented expanding the throughput of the assay
beyond a few hundred proteins. To address these challenges and
increase the scalability of our assay to many hundreds of proteins,
we added a 6His tag at the C terminus of the bait constructs to
enable afﬁnity puriﬁcation on Ni2+–NTA resins, thereby removing
the need for the dialysis and concentration steps. Initial experi-
ments demonstrated that adding a 6His tag (Bio-His) directly
Fig.1. Design of a recombinant protein tag for efﬁcient biotinylation and puriﬁcation of monomeric proteins for capture on streptavidin-coated surfaces. (A) A schematic
diagram showing the sequences of the C-terminal tags used in this study. A cartoon of a typical membrane-embedded type I cell surface receptor is shown next to the
corresponding soluble ectodomain expressed as a bait. Lollipops represent potential N-linked glycosylation sites. The sequences of the C-terminal tags are shown and named.
‘‘LN’’ marked in black is the C-terminal end of the Cd4 tag. The peptide sequence that is a substrate for the BirA enzyme is highlighted in red, and the biotinylatable lysine
residue is underlined. Flexible linkers and structurally insulating sequences are shown in purple and blue respectively, and oligo-histidine is shown in green. (B) Comparison
of the biotinylation efﬁciencies of a rat Cd200R bait protein containing different C-terminal tags. The different Cd200R bait proteins were expressed with the modiﬁed BirA
plasmid, normalized to 1 lg/ml, serially diluted on streptavidin-coated microtiter plates, and quantiﬁed by ELISA. (C) Cd200R-Bio-L-His bait proteins were cotransfected with
a codon-optimized Flag-tagged BirA enzyme (BirA–Flag) or a His8-tagged non-codon-optimized BirA (BirA–His8). Bait expression levels were normalized to 1 lg/ml, and the
relative fraction that was biotinylated was determined by ELISA after capture on a streptavidin-coated microtiter plate. (D) Bait proteins containing BLH fusion tag can be
efﬁciently puriﬁed on Ni2+–NTA resin. Rat Cd200R–BLH baits were expressed and dialyzed to remove free biotin (to enable capture of unpuriﬁed supernatants) and then
puriﬁed using Ni2+–NTA resin. Essentially all Cd200R–BLH protein was captured by the Ni2+–NTA resin (cf. before and after columns) and was efﬁciently eluted; little Cd200R–
BLH protein leached during washing. Data points in panels B to D represent means ± standard errors (nP 3).
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cient biotinylation compared with the original bait (Fig. 1B). There-
fore, we separated the Bio and 6His tags with a ﬂexible linker
sequence (BLH) and made a second version in which the ordering
of the peptides was reversed (HLB) (Fig. 1A). To determine the efﬁ-
ciency with which each tag was biotinylated using our experimen-
tal system, the ectodomain of the rat Cd200R protein was cloned
into vectors containing each of these tags, expressed, and normal-
ized, and the relative fraction of each protein that was biotinylated
was quantiﬁed by ELISA (Fig. 1B). The BLH tag was more efﬁciently
biotinylated compared with HLB (although not as good as Bioonly), suggesting that the local peptide sequence affected the activ-
ity of the BirA enzyme for its substrate (Fig. 1B). To further opti-
mize the efﬁciency of biotinylation and remove the complication
that the original secreted E. coli BirA enzyme was His8-tagged
and, therefore, would be copuriﬁed with His-tagged bait proteins
[15], we designed a secreted Flag-tagged BirA expression vector
that was codon-optimized for mammalian expression. The BirA–
Flag construct was more efﬁcient at bait protein biotinylation
using our protocol (Fig. 1C). Finally, we showed that the BLH-
tagged proteins could be successfully puriﬁed using Ni2+–NTA res-
ins (Fig. 1D). These reﬁnements in our bait construct design now
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protein libraries that can be more easily scaled.
A cost-effective platform for the convenient parallel puriﬁcation of bait
proteins from large tissue culture volumes
We have observed, despite a standardized procedure, that indi-
vidual proteins within our protein libraries are reproducibly ex-
pressed in our mammalian expression system at widely varying
levels, spanning at least four orders of magnitude [18]. Therefore,
low-expressing proteins require larger volumes of tissue culture
supernatant (often >50 ml) to produce sufﬁcient amounts for inter-
action screening. Although His-tagged proteins can be puriﬁed in
parallel using commercially available Ni2+–NTA resins arrayed in
96-well plate formats, they are not designed for sample volumes
greater than approximately 500 ll. Therefore, to conveniently
purify large numbers of different proteins from 50-ml volumes,
we designed and custom-built a puriﬁcation platform that uses
compressed air to power a pneumatic piston delivering superna-
tants loaded in disposable 50-ml syringes through a 96-well
Ni2+–NTA plate via microbore tubes at a rate of approximately
1 ml/min (Fig. 2A). This platform enables 96 50- to 100-ml samples
to be conveniently puriﬁed within a few hours to more than 90%
purity (Fig. 2B) without cross-well contamination (Fig. 2C). This
cost-effective apparatus enabled the convenient puriﬁcation of
up to 96 transfection supernatants in parallel (full design details
can be found in Additional Data File 1).
Optimization of protein immobilization on streptavidin-coated
microarrays
To construct protein microarrays containing libraries of bait
proteins that were suitable for interaction screening, we ﬁrst
determined the parameters that were important for optimal print-
ing. To ensure that the bait proteins were immobilized in an orien-
tated fashion and in an active conformation, the puriﬁed
biotinylated bait proteins were equalized, diluted in different
buffers, and arrayed on streptavidin-coated microarray slides
before being detected using an anti-Cd4 tag monoclonal antibody
and a Cy3-conjugated secondary antibody (Fig. 3A). A printing buf-
fer containing 0.02% Tween and 0.5% BSA in PBS reproducibly gave
the best results in terms of spot size and morphology using our di-
rect contact solid pin arrayer (Fig. 3A). The amount of bait protein
immobilized on the streptavidin-coated slides we used (XanTec)
showed evidence of saturation at concentrations of 400 lg/ml,
indicating that the proteins were speciﬁcally captured via the bio-
tin–streptavidin interaction. A puriﬁed but unbiotinylated Cd200
bait protein was not immobilized at 400 lg/ml, demonstrating lit-
tle capture by passive adsorption (Fig. 3B). Concentrations of
P15 lg/ml could be detected on the array with a high-afﬁnity
monoclonal antibody recognizing the anti-Cd4 tag.
Microarray AVEXIS can detect low-afﬁnity interactions
In the original AVEXIS assay, interactions were detected in
microtiter plates by probing bait arrays with a pentamerized, b-lac-
tamase-tagged prey protein followed by incubation with a colori-
metric soluble b-lactamase substrate, nitroceﬁn [15]. Because
slides are not compartmentalized, detecting interactions on a
microarray requires the use of precipitating substrates. Therefore,
wemodiﬁed the prey protein to include a C-terminal 3Flag–6His
tag that enables detection and, if necessary, puriﬁcation of the prey
protein (Fig. 4A). Captured preys were detected using an anti-Flag
HRP-conjugated secondary followed by detection using HRP-acti-
vated ﬂuorescent tyramide derivatives that are covalently captured
on the microarray. We selected the rat Cd200–Cd200R interactionas a model low-afﬁnity interaction (KD = 2 lM, t1/2 = 0.9 s at 37 C)
[34] to determine the parameters of the assay. A dilution series of
both immobilized Cd200 and Cd200R baits were probed with both
Cd200 and Cd200R unpuriﬁed prey proteins, and the interaction
was robustly detected in both bait–prey orientations (Fig. 4B).
Importantly, by screening against a dilution series of baits, we ob-
served saturation of the signal at high bait immobilization levels,
providing immediate evidence that the detected interaction was
speciﬁc.
To determine the sensitivity of the assay to the bait and prey
concentrations, the bait arrays were probed with a range of prey
activities ranging from 196 to 2.42 units, where 1 unit is deﬁned
as the amount of prey protein that can turn over 1 nmol of nitroce-
ﬁn substrate per minute. We observed that the ability to detect
interactions was more sensitive to the immobilized bait concentra-
tion than the activity of the prey (Figs. 4C–F). For example, diluting
a bait that gave a saturated positive detection signal by only 3-fold
was sufﬁcient to reduce the signal below the detection threshold
(Figs. 4C and 4E). In contrast, signals from a bait dilution that
was sensitive to the range of prey activities used were still above
the detection threshold despite using an 81-fold dilution range; in-
deed, the relationship between prey dilution and signal was essen-
tially linear (Figs. 4D and 4F). These results established that bait
proteins should be immobilized at concentrations P133 ng/ll to
robustly detect a typical low-afﬁnity extracellular protein interac-
tion with an equilibrium dissociation constant within the micro-
molar (lM) range. We also used this experiment to select a
minimum prey activity of 65.3 U for our subsequent screens.
Quantitative benchmarking of the microarray AVEXIS using
interactions with the zebraﬁsh Jam family
Although the rat Cd200–Cd200R interaction has a relatively low
afﬁnity with a KD of approximately 2 lM, there are several re-
ported receptor–ligand interactions that are considerably weaker
than this [35,36] and it has been estimated that interactions as
weak as 50 lM (t1/2  0.1 s) are sufﬁcient to drive spontaneous
alignment of apposing membranes [16]. To quantify the sensitivity
limit of our assay, we screened for interactions within the family of
six paralogous receptor proteins belonging to the zebraﬁsh junc-
tional cell adhesion molecule (JAM) family (Fig. 5A). Results from
our group have shown, using mutant zebraﬁsh and cellular trans-
plantation studies, that the interaction between JamB1 and JamC1
is necessary for myoblast fusion in vivo [37]. We have also system-
atically quantiﬁed the monomeric interaction strengths among all
six proteins using surface plasmon resonance (SPR) (Powell et al.,
in preparation), providing us with a quantiﬁed set of interactions
whose strengths range from the relatively high-afﬁnity JamB1–
JamC2 interaction (t1/2 > 2 s) to the JamA1–JamC2 interaction that
can be barely detected (t1/2 < 0.4 s) (Fig. 5B). All six Jam family bait
proteins were immobilized as a dilution series (Fig. 5A) and probed
using a set of the corresponding six pentameric preys. The JamB1–
JamC1 interaction (t1/2 = 1.9 s), which is known to be physiologi-
cally relevant in vivo [37], was robustly detected (Fig. 5B), as was
the higher afﬁnity JamB1–JamC2 interaction (t1/2 > 2 s). Both of
these expected interactions were detected in both bait–prey orien-
tations. The very weak JamC2–JamA1 interaction (t1/2 < 0.4 s) was
detected in just one bait–prey orientation, and an interaction be-
tween JamA2 and JamC2 that had not been detected by our SPR
studies was now observed, again in just one orientation (Fig. 5B).
The very weak (t1/2 < 0.4 s) JamB2–JamC1 and JamB2–JamC2 inter-
actions were not detected. None of the homophilic interactions
was detected, possibly due to highly avid prey–prey interactions
that prevent prey–bait interactions; this prey ‘‘masking’’ effect
was also observed in the plate-based assay [15]. Interestingly,
the strength of the interaction correlated with the ability to detect
Fig.2. A protein puriﬁcation system for the parallel puriﬁcation of 96 large tissue culture volumes. (A) The loading press can purify up to 96 50- to 100-ml samples of His-
tagged proteins in parallel. It consists of a pneumatic piston attached to an aluminum plate that is used to drive tissue culture supernatants loaded in 50-ml disposable
syringes through tubes that are connected to a holding block containing the 96-well Ni2+–NTA resin ﬁlter plate. (B) Proteins are puriﬁed to greater than 90% purity using the
custom loading apparatus. A typical human cell surface receptor protein (TREML) was cloned into the BLH vector and expressed, and 50 ml of spent supernatant was loaded
onto a single well of a 96-well microtiter plate containing Ni2+–NTA resin. Three serial 200-ll elutions were performed (E1–E3), and 20 ll of a 1:4000 dilution was loaded and
resolved by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) under reducing conditions and detected using silver staining. S = 18 ll spent
supernatant; FT = 18 ll ﬂow-through; M = markers. (C) No cross-well contamination is detected using the protein puriﬁcation system. A puriﬁcation experiment was set up
with 48 transfection supernatants and intentionally included blank wells containing tissue culture medium alone to test for cross-well contamination. Eluates from the plate
(including neighboring blank wells) were diluted 1:4000, and 20 ll was resolved by SDS–PAGE under reducing conditions and detected by silver staining. The gel shows
representative puriﬁed bait proteins at the expected mass together with the eluate from neighboring blank wells showing no cross-well contamination.
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strong JamB1–JamC2 interaction was easily detected at a bait con-
centration of 44 ng/ll, whereas the weaker interactions were not
(Fig. 5C). This suggests that it may be possible to estimate an
approximate afﬁnity for an interaction during the primary screen
by probing a serial dilution of bait proteins despite the unpredict-
able nature of avidity gains achieved by multimerization. We also
observed that the JamB1–JamC2 and JamB1–JamC1 interaction
exhibited the same sensitivity to the level of bait immobilization
regardless of the bait–prey orientation used to detect it (Fig. 5C).
This suggests that the bait and prey activities (fraction of func-
tional protein) are comparable for each interaction. Although this
might be expected for the prey protein in solution, others have
observed an unexpectedly wide range of protein activities when
similar proteins are immobilized on a solid substrate [38].Discussion
Deﬁning protein interaction networks on an increasingly large
scale to understand how biological processes are coordinately reg-
ulated has been a focus of recent research interest. These efforts
have relied on a small number of high-throughput assays such as
biochemical puriﬁcation followed by mass spectrometry [39,40],
yeast two-hybrid screening [41,42], and other protein complemen-
tation assays [43]. Although these approaches have revealed a
great deal regarding the architecture of intracellular protein inter-
action networks, none of these assays is generally suitable for
detecting low-afﬁnity extracellular interactions. To address this
problem, several scalable assays speciﬁcally designed to detect
extracellular interactions have been developed [6,9,11–13,15] but
are practically limited to screening modest library sizes of several
Fig.3. Optimization of biotinylated bait immobilization on streptavidin-coated microarrays. (A) A puriﬁed biotinylated Cd200R–BLH protein was serially diluted at the
indicated concentrations in three different PBS/0.5% BSA-based buffers before being printed using 400-lm-diameter solid pins on streptavidin-coated slides (XanTec). Buffers
were based on a PBS/0.5% BSA solution but contained either 0.02% Tween 20 and 1% polyethylene glycol (PEG, average mass = 8 kDa) or 10% glycerol. The buffer containing
0.02% Tween 20 reproducibly immobilized the most protein with the best spot morphology. (B) The top panel shows a representative image of a protein microarray
containing a dilution series of six different proteins that were arrayed on a streptavidin-coated slide before being incubated with an anti-rat Cd4 monoclonal antibody
followed by an anti-mouse Cy3-conjugated secondary. The bottom panel graphically shows quantitation of the ﬂuorescence intensities from triplicate arrays on the same
slide. Biotinylated bait proteins were speciﬁcally captured, as shown by saturation of immobilized bait at 400 lg/ml and lack of immobilization of an unbiotinylated control.
The biotinylated anti-Cd4 monoclonal antibody (Anti-Cd4-Bio) serves as a positive control. Data points represent the means ± standard errors (n = 3).
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known to contain several thousand [1]. Here, we have shown that
it is possible to implement the AVEXIS assay as a protein micro-
array format, which, together with improved sample handling
and the development of custom-built protein sample preparation
hardware, makes extracellular protein interaction screening feasi-
ble on a genome-wide scale.
Miniaturizing the AVEXIS assay on a microarray compared with
the microtiter plate format has several advantages. The amount of
protein required per interaction test has been dramatically reduced
by approximately ﬁve orders of magnitude. This now reduces the
amount of sample preparation time required and is particularly
important for those proteins that are expressed at low levels. It also
enables an increase in the number of interaction screens that can
be performed with the same protein preparation, enabling more
replicates to be performed with a wider range of protein concen-
trations. This latter point is of particular value because by screen-
ing against a dilution series of bait proteins it was possible to
determine whether binding events were saturable (and therefore
speciﬁc) and to estimate a binding afﬁnity directly from the screen.
The observation that the known binding afﬁnity of an interaction
correlated with its dose sensitivity across the bait dilutions used
was a surprise given the unpredictable gain in binding avidity
caused by multimerization. This is likely due to the fact that we
used a similar structural class of receptor proteins in the experi-
ments described here (all are type I cell surface proteins containing
two immunoglobulin superfamily domains that interact with a 1:1stoichiometry [34,37]), and we would not expect this to be gener-
ally true of receptors belonging to different structural classes. An
important aspect of the approach described here is the quantitative
determination of the assay detection thresholds using variable
parameters such as the bait and prey levels. By using a panel of
known interaction strengths, we determined that our microarray-
based assay is capable of detecting interactions that are known
to be physiologically relevant and that are thought to be on the
lower limit for in vivo signiﬁcance. Finally, a microarray is more
convenient for storing and distributing a large number of proteins
in a format that is suitable for a range of different screening
approaches.
The development of the dual biotin–His tag and the custom
loading apparatus has signiﬁcantly improved the throughput and
convenience of protein sample preparation when using the large
supernatant volumes required by mammalian expression systems.
The puriﬁcation of the biotinylated proteins using the oligo–His tag
has removed the need for the cumbersome dialysis steps and has
the additional advantage that the proteins can be eluted from the
microtiter plate in small (50–300 ll) volumes so that very high
concentrations (>10 mg/ml) of puriﬁed proteins can be achieved.
This approach also retains the advantage of irreversibly capturing
the monobiotinylated bait proteins on streptavidin-coated solid
phases in an orientated manner that, as we showed here, may re-
duce the wide variance in immobilized protein activity that has
been observed when proteins are captured nonspeciﬁcally by pas-
sive adsorption [38]. Retaining the b-lactamase enzyme in the prey
Fig.4. Microarray AVEXIS speciﬁcally detects low-afﬁnity extracellular interactions with high sensitivity. (A) A schematic diagram of the pentamerized prey protein and how
it is used in the microarray-based AVEXIS assay. Whole ectodomains of cell surface receptor proteins (yellow) are expressed as soluble Cd4-tagged proteins pentamerized by a
peptide from the cartilage oligomeric matrix protein (COMP), followed by the b-lactamase enzyme and a triple-Flag tag for detection and a 6His tag for puriﬁcation if
necessary. The prey is used to probe arrays of bait proteins immobilized on a streptavidin-coated microarray slide. Captured Flag-tagged preys are detected by an anti-Flag
HRP-conjugated antibody and then quantiﬁed using the deposition of an Alexa Fluor 555 tyramide derivative. (B) Detection of the rat Cd200–Cd200R interaction in both bait–
prey orientations by microarray AVEXIS. Serial dilutions of biotinylated rat Cd200–BLH and Cd200R–BLH were immobilized and probed with 196 U of Cd200R (left panel) and
CD200 (right panel) preys. The Cd200–Cd200R interaction (within red boxes) was detected in both bait–prey orientations. Serial dilutions of a biotinylated anti-Cd4 antibody
(to directly capture the prey via its Cd4 tag) and biotinylated HRP were immobilized as positive controls. (C–F) Determining the sensitivity of the assay to bait and prey
activities. Panels C and E show how ﬂuorescence intensity varies according to the bait and prey dilutions when either Cd200 (C) or Cd200R (E) are immobilized as the bait.
Panels D and F show a slice through the data shown in panels C and E at bait concentrations of 44 and 133 ng/ll, respectively, illustrating the essentially linear response of the
signal to the prey activity. RFU, relative ﬂuorescence units. Data points are means ± standard errors (nP 3).
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itate prey normalization prior to addition to the slides and is fully
compatible with performing the assay on microtiter plates. The rat
Cd4d3 + 4 tag in both the bait and prey provides ﬂexibility in using
other antibody-based methods for normalizing the protein expres-
sion levels, and although the presence of the Cd4d3 + 4 tag in the
prey might seem redundant, we found it to be useful when usedtogether with a biotinylated anti-Cd4 monoclonal antibody as a
prey capture positive control (as shown in Figs. 3 and 4). The
Cd4d3 + 4 tag [44] has been used by several laboratories over a
number of years without any reports of unexpected interactions
[34,45–49]. The addition of a His-tag C terminal to the b-lactamase
also enables puriﬁcation of the prey in a similar manner to the
baits. Although we showed that it is not necessary to purify the
Fig.5. Quantitative benchmarking of the microarray AVEXIS using interactions
within the zebraﬁsh Jam family. (A) All six members of the zebraﬁsh Jam family
were expressed as biotinylated baits, puriﬁed, normalized, serially diluted, and
arrayed on streptavidin-coated slides before detection with an anti-Cd4 primary
antibody and a Cy3-conjugated goat anti-mouse secondary antibody. The image
shows that similar levels of Jam bait proteins were immobilized on the slide. (B)
Graphical representation of expected and observed interactions of different
afﬁnities within the zebraﬁsh Jam family. The expected (left panel) interactions
within the zebraﬁsh Jam family were grouped according to their afﬁnities
(red = high afﬁnity [t1/2 > 2 s]; orange = medium afﬁnity [0.4 < t1/2 < 2 s]; yel-
low = low afﬁnity [t1/2 < 0.4 s]). The observed interactions using the microarray
screening approach are depicted graphically in the right panel. (C) The afﬁnity of
interactions detected on the microarray correlated with the sensitivity to bait
immobilization level in both bait–prey orientations. The ability to detect the four
interactions within the Jam family as a function of the immobilized bait level was
determined using microarray AVEXIS. Higher afﬁnity interactions (e.g., JamB1–
JamC2) were less sensitive to the bait immobilization level, and the same
interaction showed the same sensitivity to the bait immobilization level in both
bait–prey orientations. RFU, relative ﬂuorescence units. Data points are
means ± standard errors (nP 3).
52 Identiﬁcation of extracellular protein interactions / Y. Sun et al. / Anal. Biochem. 424 (2012) 45–53prey proteins for screening, this now provides the ability to easily
concentrate poorly expressing prey proteins by factors greater than
500-fold to levels that are sufﬁcient to be included in screens.Previously, low-expressing prey protein solutions were concen-
trated using centrifugation ﬁlters that limited concentration
factors to approximately 10-fold. The loading device described in
our article can be constructed on a limited budget ($5000), mak-
ing it accessible to a wide range of laboratories. It is compatible
with any standard 96-well plate format and, therefore, can be used
for a range of applications such as purifying antibodies on protein
G or protein A plates.
The arrayed receptor protein microarray slides are not limited
to the study of extracellular protein interactions. We envisage that
these receptor arrays will also be very useful for systematically
studying interactions using whole cells or pathogens such as bac-
teria and viruses. In addition, these slides could be used to screen
complex biological tissues such as serum samples for the identiﬁ-
cation of diagnostic disease markers.
In conclusion, by developing new protein tags and streamlining
the sample preparation procedures, we have used protein micro-
arrays to miniaturize and improve the AVEXIS assay that is capable
of detecting low-afﬁnity extracellular protein interactions. By
reducing the amount of protein required, the size of the screens
that can be performed has increased signiﬁcantly. We determined
the experimental parameters necessary to detect interactions as
weak as 50 lM, which are considered as a lower limit for physio-
logical signiﬁcance [1,16]. The microarray has advantages over
the plate-based format of estimating interaction afﬁnities and
observing saturable (speciﬁc) binding behaviors during the initial
screen, thereby providing immediate additional criteria for select-
ing which interactions should be prioritized for further study. The
human genome is believed to contain approximately 2000 receptor
and secreted proteins that would be suitable for interaction screen-
ing using the AVEXIS approach and whose extracellular interac-
tions are unlikely to be detected using other scalable protein
interaction techniques [1]. Because the extracellular regions of
receptor proteins are accessible to systematically delivered drugs
such as therapeutic antibodies, they are often described as ‘‘drug-
gable’’ targets, making systematically determined extracellular
protein interaction networks of particular importance. The minia-
turization of the AVEXIS assay and its technological improvements
now make whole-genome screening for low-afﬁnity extracellular
protein interactions a possibility.
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